- Emerging Therapies for Hepatitis C
-
Kim DY, Ahn SH, Han KH
- KMID: 2070056
- Gut Liver.
- 2014 Sep;8(5):471-479.
- doi: 10.5009/gnl14083
The combination of pegylated interferon (PEG-IFN) and ribavirin (RBV), the current therapy for hepatitis C virus (HCV) infection, has saved the lives of many HCV-infected patients. Direct-acting antivirals (DAAs) target... -
- CITED
-
- Close
- SHARE
-
- Close
- Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
-
Yim HJ, Hwang SG
- KMID: 1705199
- Clin Mol Hepatol.
- 2013 Sep;19(3):195-209.
- doi: 10.3350/cmh.2013.19.3.195
Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Cytomegalovirus IE1 Protein Enhances Herpes Simplex Virus Type 1-induced Syncytial Formation in U373MG Cells
-
Shin KC, Park CG, Hwang ES, Cha CY
- KMID: 1107532
- J Korean Med Sci.
- 2008 Dec;23(6):1046-1052.
- doi: 10.3346/jkms.2008.23.6.1046
Co-infection of herpes simplex virus type 1 (HSV-1) and human cytomegalovirus (HCMV) is not uncommon in immunocompromised hosts. Importantly, organ transplant recipients concurrently infected with HSV-1 and HCMV have a... -
- CITED
-
- Close
- SHARE
-
- Close
